These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 9250423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD, Plosker GL.
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility of yeasts].
    Wildfeuer A, Laufen H, Schmalreck AF, Yeates RA, Zimmermann T.
    Mycoses; 1996; 39 Suppl 2():51-7. PubMed ID: 9198746
    [Abstract] [Full Text] [Related]

  • 7. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
    Haria M, Bryson HM, Goa KL.
    Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical pharmacokinetics of fluconazole.
    Debruyne D, Ryckelynck JP.
    Clin Pharmacokinet; 1993 Jan; 24(1):10-27. PubMed ID: 8448970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Level of evidence for therapeutic drug monitoring of fluconazole].
    Venisse N, Le Guellec C.
    Therapie; 2011 Jan; 66(2):97-101. PubMed ID: 21635855
    [Abstract] [Full Text] [Related]

  • 15. Fluconazole: a new antifungal agent.
    Kowalsky SF, Dixon DM.
    Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis.
    Perry CM, Whittington R, McTavish D.
    Drugs; 1995 Jun; 49(6):984-1006. PubMed ID: 7641607
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses.
    Latimer FG, Colitz CM, Campbell NB, Papich MG.
    Am J Vet Res; 2001 Oct; 62(10):1606-11. PubMed ID: 11592327
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of antifungal agents in onychomycoses.
    Debruyne D, Coquerel A.
    Clin Pharmacokinet; 2001 Oct; 40(6):441-72. PubMed ID: 11475469
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of fluconazole in patients with mycotic infection].
    Matsushima T, Ikeda H, Tomizawa S, Nakamura J, Adachi M, Kawanishi M, Tanabe J, Tano Y.
    Jpn J Antibiot; 1989 Jan; 42(1):153-63. PubMed ID: 2540361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.